(Q36702069)

15 August 2017

1 reference

title

Inhibiting costimulatory activation of T cells : a viable treatment option for rheumatoid arthritis? (English)

1 reference

15 August 2017

0 references

Louise C Pollard

1

1 reference

15 August 2017

publication date

1 January 2007

1 reference

15 August 2017

1 reference

15 August 2017

volume

67

1 reference

15 August 2017

issue

1

1 reference

15 August 2017

page(s)

1-9

1 reference

https://scigraph.springernature.com/pub.10.2165/00003495-200767010-00001

15 August 2017

exact match

0 references

cites work

Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.

1 reference

Crossref

https://api.crossref.org/works/10.2165%2F00003495-200767010-00001

The estimation of a preference-based measure of health from the SF-36.

21 January 2018

1 reference

12 December 2020

CTLA-4 ligation blocks CD28-dependent T cell activation

1 reference

12 December 2020

Treatment of rheumatoid arthritis with the selective costimulation modulator abatacept: twelve-month results of a phase iib, double-blind, randomized, placebo-controlled trial

1 reference

12 December 2020

Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells

1 reference

12 December 2020

Transfer of rheumatoid arthritis into severe combined immunodeficient mice. The pathogenetic implications of T cell populations oligoclonally expanding in the rheumatoid joints

1 reference

12 December 2020

Treatment of rheumatoid arthritis patients with abatacept and methotrexate significantly improved health-related quality of life.

1 reference

12 December 2020

Cytokine production by synovial T cells in rheumatoid arthritis

1 reference

12 December 2020

Improved health-related quality of life for rheumatoid arthritis patients treated with abatacept who have inadequate response to anti-TNF therapy in a double-blind, placebo-controlled, multicentre randomized clinical trial

1 reference

12 December 2020

CD28/B7 system of T cell costimulation

1 reference

12 December 2020

Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice

1 reference

12 December 2020

Assessment of rheumatoid arthritis using a modified scoring method on digitized and original radiographs

1 reference

12 December 2020

Signals and signs for lymphocyte responses

1 reference

12 December 2020

Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent

1 reference

12 December 2020

Measurement of patient outcome in arthritis

1 reference

12 December 2020

CTLA-4 can function as a negative regulator of T cell activation

1 reference

12 December 2020

1 reference

12 December 2020

Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig

1 reference

12 December 2020

American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis

1 reference

12 December 2020

Costimulatory blockade in patients with rheumatoid arthritis: a pilot, dose-finding, double-blind, placebo-controlled clinical trial evaluating CTLA-4Ig and LEA29Y eighty-five days after the first infusion

1 reference

12 December 2020

Genetic insights into disease mechanisms of autoimmunity

1 reference

12 December 2020

Abatacept for rheumatoid arthritis refractory to tumor necrosis factor alpha inhibition

1 reference

12 December 2020

CTLA-4 is a second receptor for the B cell activation antigen B7

1 reference

12 December 2020

The autoimmune pathogenesis of rheumatoid arthritis: role of autoreactive T cells and new immunotherapies

1 reference

12 December 2020

Cytokine pathways and joint inflammation in rheumatoid arthritis

1 reference

12 December 2020

10.2165/00003495-200767010-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

15 August 2017

1003986668

0 references

1 reference